These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138 [TBL] [Abstract][Full Text] [Related]
7. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251 [TBL] [Abstract][Full Text] [Related]
8. Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. Moezzi L; Keshavarz Z; Ranjbaran R; Aboualizadeh F; Behzad-Behbahani A; Abdullahi M; Ramezani A; Samsami A; Sharifzadeh S Int J Fertil Steril; 2016; 10(1):62-70. PubMed ID: 27123202 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy. Isakson P; Pardi C Blood Transfus; 2023 Nov; 21(6):472-478. PubMed ID: 36795345 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma. Ahmadi MH; Pourfathollah AA; Rabiee M; Amirizadeh N J Reprod Infertil; 2022; 23(2):128-134. PubMed ID: 36043134 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus. Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy. Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271 [TBL] [Abstract][Full Text] [Related]
16. Determination of fetal rhesus d status by maternal plasma DNA analysis. Aykut A; Onay H; Sagol S; Gunduz C; Ozkinay F; Cogulu O Balkan J Med Genet; 2013 Dec; 16(2):33-8. PubMed ID: 24778561 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA. Rather RA; Dhawan V; Saha SC Indian J Med Res; 2019 Jul; 150(1):62-66. PubMed ID: 31571630 [TBL] [Abstract][Full Text] [Related]
18. Genotyping approach for non-invasive foetal RHD detection in an admixed population. Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427 [TBL] [Abstract][Full Text] [Related]
19. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782 [TBL] [Abstract][Full Text] [Related]